Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49M | Sell |
1,058,349
-221,606
| -17% | -$10.3M | 0.16% | 98 |
|
|
2025
Q1 | $78.1M | Buy |
1,279,955
+286,145
| +29% | +$17.5M | 0.28% | 62 |
|
|
2024
Q4 | $56.2M | Sell |
993,810
-31,864
| -3% | -$1.8M | 0.19% | 78 |
|
|
2024
Q3 | $53.1M | Buy |
1,025,674
+42,456
| +4% | +$2.2M | 0.17% | 101 |
|
|
2024
Q2 | $40.8M | Sell |
983,218
-65,906
| -6% | -$2.74M | 0.13% | 108 |
|
|
2024
Q1 | $56.9M | Buy |
1,049,124
+2,144
| +0.2% | +$116K | 0.45% | 53 |
|
|
2023
Q4 | $53.7M | Sell |
1,046,980
-888,942
| -46% | -$45.6M | 0.45% | 52 |
|
|
2023
Q3 | $112M | Buy |
1,935,922
+266,112
| +16% | +$15.4M | 1.04% | 16 |
|
|
2023
Q2 | $107M | Sell |
1,669,810
-200,192
| -11% | -$12.8M | 0.94% | 18 |
|
|
2023
Q1 | $130M | Buy |
1,870,002
+31,802
| +2% | +$2.2M | 1.21% | 11 |
|
|
2022
Q4 | $132M | Buy |
1,838,200
+198,230
| +12% | +$14.3M | 1.34% | 8 |
|
|
2022
Q3 | $117M | Buy |
1,639,970
+102,316
| +7% | +$7.27M | 1.36% | 8 |
|
|
2022
Q2 | $120M | Sell |
1,537,654
-239,989
| -14% | -$18.8M | 1.3% | 11 |
|
|
2022
Q1 | $131M | Buy |
1,777,643
+805,626
| +83% | +$59.4M | 1.13% | 16 |
|
|
2021
Q4 | $60.8M | Sell |
972,017
-35,735
| -4% | -$2.23M | 0.51% | 41 |
|
|
2021
Q3 | $59.6M | Sell |
1,007,752
-485,964
| -33% | -$28.8M | 0.53% | 39 |
|
|
2021
Q2 | $99M | Buy |
1,493,716
+480,293
| +47% | +$31.8M | 0.86% | 22 |
|
|
2021
Q1 | $64M | Buy |
1,013,423
+98,389
| +11% | +$6.21M | 0.47% | 27 |
|
|
2020
Q4 | $55.1M | Buy |
+915,034
| New | +$55.1M | 0.36% | 34 |
|